» Articles » PMID: 9165005

Regulation by Thyroid-stimulating Hormone of Sodium/iodide Symporter Gene Expression and Protein Levels in FRTL-5 Cells

Overview
Journal Endocrinology
Specialty Endocrinology
Date 1997 Jun 1
PMID 9165005
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the mechanism of I- transport stimulation by TSH, we studied the effects of TSH on Na+/I- symporter (NIS) messenger RNA (mRNA) and protein levels in FRTL-5 cells and correlated these with I- transport activity. When 1 mU/ml TSH was added to quiescent FRTL-5 cells, a 12-h latency was observed before the onset of increased I- transport activity, which reached a maximum [approximately 27 times basal (5H medium) levels] at 72 h. In contrast, Northern blot analysis, using rat NIS complementary DNA as a probe, revealed that addition of TSH to these cells significantly increased NIS mRNA at 3-6 h, reaching a maximum after 24 h (approximately 5.9 times basal levels). Forskolin and (Bu)2cAMP mimicked this stimulatory effect on both the I- transport activity and mRNA levels. D-ribofranosylbenzimidazole, a transcription inhibitor, almost completely blocked TSH-induced stimulation of I- transport and NIS mRNA levels. Western blot analysis demonstrated that TSH increased NIS protein levels at 36 h, reaching a maximum at 72 h, in parallel with the kinetics of TSH-induced I- transport activity. However, it also showed that the amount of NIS protein already present in FRTL-5 cell membranes before the addition of TSH was about one third of the maximum level induced by TSH. These results indicate that stimulation of I- transport activity by TSH in thyrocytes is partly due to a rapid increase in NIS gene expression, followed by a relatively slow NIS protein synthesis. However, the existence of an abundant amount of protein in quiescent FRTL-5 cells with very low I- transport activity also suggests that this activity is controlled by another TSH-regulated factor(s).

Citing Articles

Development and validation of long-acting recombinant human TSH using SAFA technology.

Kim D, Kang M, Lee S, Cho Y, Zi G, An J Endocr Relat Cancer. 2025; 32(4).

PMID: 39907208 PMC: 11850033. DOI: 10.1530/ERC-24-0284.


Derivation of transplantable human thyroid follicular epithelial cells from induced pluripotent stem cells.

Undeutsch H, Posabella A, Alber A, Bawa P, Villacorta-Martin C, Wang F Stem Cell Reports. 2024; 19(12):1690-1705.

PMID: 39515316 PMC: 11751801. DOI: 10.1016/j.stemcr.2024.10.004.


Advancing Environmental Toxicology : From Immortalized Cancer Cell Lines to 3D Models Derived from Stem Cells.

Li H, Yin N, Yang R, Faiola F Environ Health (Wash). 2024; 2(6):332-349.

PMID: 39473468 PMC: 11503916. DOI: 10.1021/envhealth.3c00199.


Stimulating thyroglobulin to TSH ratio predict long-term efficacy of I therapy in patients with differentiated thyroid cancer after total thyroidectomy: a retrospective study.

Yin X, Lu C, Sun D, Ji Y, Wang Y, Zheng H Endocrine. 2024; 84(3):1064-1071.

PMID: 38172344 DOI: 10.1007/s12020-023-03663-6.


Environmental Endocrinology: Parabens Hazardous Effects on Hypothalamic-Pituitary-Thyroid Axis.

Azeredo D, de Sousa Anselmo D, Soares P, Graceli J, Magliano D, Miranda-Alves L Int J Mol Sci. 2023; 24(20).

PMID: 37894927 PMC: 10607526. DOI: 10.3390/ijms242015246.